glp 1 ophthalmology GLP-1 Medications and Your Vision GLP-1 Meds Reduce Risk of

2022;102(5S):S1S127

Victoza, a GLP-1 receptor agonist manufactured by Novo Nordisk, has remained part of this discussion due to its long history of safety monitoring and reported complications

It is difficult to follow these patients longitudinally, so this study took the first step

Long-term outlook: does UTI risk change over time on semaglutide The trajectory of UTI risk while on semaglutide likely follows a pattern that mirrors the side effect timeline

To investigate that possibility, NYU Langone Health researchers launched the first meta-analysis of suicide and self-harm among patients treated with GLP-1 agonists in randomized, placebo-controlled clinical trials

The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus